Literature DB >> 26827874

Mobilization of hematopoietic stem cells with highest self-renewal by G-CSF precedes clonogenic cell mobilization peak.

Ingrid G Winkler1, Eliza Wiercinska2, Valerie Barbier1, Bianca Nowlan1, Halvard Bonig3, Jean-Pierre Levesque4.   

Abstract

Harvest of granulocyte colony-stimulating factor (G-CSF)-mobilized hematopoietic stem cells (HSCs) begins at day 5 of G-CSF administration, when most donors have achieved maximal mobilization. This is based on surrogate markers for HSC mobilization, such as CD34(+) cells and colony-forming activity in blood. However, CD34(+) cells or colony-forming units in culture (CFU-C) are heterogeneous cell populations with hugely divergent long-term repopulation potential on transplantation. HSC behavior is influenced by the vascular bed in the vicinity of which they reside. We hypothesized that G-CSF may mobilize sequentially cells proximal and more distal to bone marrow venous sinuses where HSCs enter the blood. We addressed this question with functional serial transplantation assays using blood and bone marrow after specific time points of G-CSF treatment in mice. We found that in mice, blood collected after only 48 hours of G-CSF administration was as enriched in serially reconstituting HSCs as blood collected at 5 days of G-CSF treatment. Similarly, mobilized Lin(-)CD34(+) cells were relatively enriched in more primitive Lin(-)CD34(+)CD38(-) cells at day 2 of G-CSF treatment compared with later points in half of human donors tested (n = 6). This suggests that in both humans and mice, hematopoietic progenitor and stem cells do not mobilize uniformly according to their maturation stage, with most potent HSCs mobilizing as early as day 2 of G-CSF.
Copyright © 2016 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26827874     DOI: 10.1016/j.exphem.2016.01.001

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  6 in total

1.  Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells.

Authors:  Darja Karpova; Julie K Ritchey; Matthew S Holt; Grazia Abou-Ezzi; Darlene Monlish; Lena Batoon; Susan Millard; Gabriele Spohn; Eliza Wiercinska; Ezhil Chendamarai; Wei Yang; Stephanie Christ; Leah Gehrs; Laura G Schuettpelz; Klaus Dembowsky; Allison R Pettit; Michael P Rettig; Halvard Bonig; John F DiPersio
Journal:  Blood       Date:  2017-04-11       Impact factor: 22.113

2.  Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells.

Authors:  Darja Karpova; Michael P Rettig; Julie Ritchey; Daniel Cancilla; Stephanie Christ; Leah Gehrs; Ezhilarasi Chendamarai; Moses O Evbuomwan; Matthew Holt; Jingzhu Zhang; Grazia Abou-Ezzi; Hamza Celik; Eliza Wiercinska; Wei Yang; Feng Gao; Linda G Eissenberg; Richard F Heier; Stacy D Arnett; Marvin J Meyers; Michael J Prinsen; David W Griggs; Andreas Trumpp; Peter G Ruminski; Dwight M Morrow; Halvard B Bonig; Daniel C Link; John F DiPersio
Journal:  J Clin Invest       Date:  2019-05-14       Impact factor: 14.808

Review 3.  Bone Marrow Niches and Tumour Cells: Lights and Shadows of a Mutual Relationship.

Authors:  Valentina Granata; Laura Crisafulli; Claudia Nastasi; Francesca Ficara; Cristina Sobacchi
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

4.  Macrophage Responses to Environmental Stimuli During Homeostasis and Disease.

Authors:  Adil Rasheed; Katey J Rayner
Journal:  Endocr Rev       Date:  2021-07-16       Impact factor: 19.871

Review 5.  Cytokine-induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche.

Authors:  Evert-Jan F M de Kruijf; Willem E Fibbe; Melissa van Pel
Journal:  Ann N Y Acad Sci       Date:  2019-04-21       Impact factor: 5.691

6.  Albumin Modifies Responses to Hematopoietic Stem Cell Mobilizing Agents in Mice.

Authors:  Eva Danner; Halvard Bonig; Eliza Wiercinska
Journal:  Cells       Date:  2019-12-18       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.